Therapeutic goods policy
Ken is a public health physician with an interest in the promotion and regulation of therapeutic goods. He is an advocate of evidence-based medicine and a critic of drug promotion by pharmaceutical companies and unproven diet products. Ken was a member of the expert group that drafted the World Health Organization “Ethical Criteria for Medicinal Drug Promotion” and also the Commonwealth Pharmaceutical Health and Rational use of Medicines (PHARM) Committee that formulated the Quality Use of Medicines (QUM) pillar of Australian medicines policy. He has also worked on medicinal drug policy in Southeast Asia, Croatia, and Jordan.
Ken recently served on the Therapeutic Goods Administration (TGA) Transparency Review Panel, the Working Group on Promotion of Therapeutic Products, Medicines Australia Code Review Panel and the Australian Government’s Natural Therapy Review Advisory Committee.